AzTrials
AzTrials

ArthritisVRHArthrisisNCT06833905

Combining Virtual Reality and Hypnosis to Alleviate Chronic Pain in Elderly Patients with Hand Arthritis

A study testing Virtual reality: Beach, Virtual Reality: Forest and Hypnosis: Magic Hand in people with Arthritis and Arthritis/Arthrosis, run by Ciusss de L'Est de l'Île de Montréal.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this pilot randomized clinical trial is to test the efficacy of an intervention combining virtual reality and hypnosis on decreasing pain and improving quality of life in elderly patients with hand arthritis. Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
Virtual reality: Beach, Virtual Reality: Forest and Hypnosis: Magic Hand
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
No sites listed yet
Study dates
Apr 2025to Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Fluent in French
  • Being diagnosed with hand arthrisis
  • Reporting an invalidating chronic pain in hand related to the condition

Who cannot join

  • Experiencing a medical condition altering the ability to consent or participate in the study
  • Experiencing cognitive disorders; Experiencing sensory disorders (deafness, blindness)

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Combining Virtual Reality and Hypnosis to Alleviate Chronic Pain in Elderly Patients with Hand Arthritis: a Pilot Randomized Clinical Trial

The goal of this pilot randomized clinical trial is to test the efficacy of an intervention combining virtual reality and hypnosis on decreasing pain and improving quality of life in elderly patients with hand arthritis. The main questions it aims to answer are:

  • Does the intervention allow for an improvement of patient reported outcomes related to pain and quality of life?
  • Does the intervention allow for an improvement of physiological variables related to pain? Researchers will compare intervention group to a passive control group (i.e., waiting list with treatment as usual).

Participants in the intervention group will be provided a virtual reality headset allowing them to beneficiate from the virtual reality and hypnosis modules.

Being tested
Virtual reality: Beach, Virtual Reality: Forest, Hypnosis: Magic Hand, Hypnosis: Pain Manipulation, Session 1bis - 1 week
Keywords
virtual reality, hypnosis, arthritis, pain, quality of life, elderly
Medical subject headings
Arthritis, Osteoarthritis, Arthritis, Rheumatoid, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual reality: BeachBehavioural

    Session 1 or 2 (counterbalanced): Exposure to a beach landscape

  • Virtual Reality: ForestBehavioural

    Session 1 or 2 (counterbalanced): Exposure to a forest landscape

  • Hypnosis: Magic HandBehavioural

    Session 3 or 4 (counterbalanced): Exposure to a hypnosis technique: the magic hand

  • Hypnosis: Pain ManipulationBehavioural

    Session 3 or 4 (counterbalanced): Exposure to a hypnosis technique: manipulating the pain

  • Session 1bis - 1 weekBehavioural

    Repetition of the Session 1 one week after Session 4

  • Follow-upBehavioural

    Repetition of the Session 1 three weeks after Session 4

Study groups in NCT06833905
Study groupRoleWhat they receive
Combined virtual reality and hypnosisExperimentalThe intervention consist in 4 different sessions with the VR headset, two consisting in presenting landscapes (i.e., beach, forest) and two consisting in hypnosis techniques (i.e., magic hand, manipulating hand).
Receives: Behavioral: Virtual reality: Beach; Behavioral: Virtual Reality: Forest; Behavioral: Hypnosis: Magic Hand; Behavioral: Hypnosis: Pain Manipulation; Behavioral: Session 1bis - 1 week; Behavioral: Follow-up
Waiting listNo interventionThe control group consist in a waiting list.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived pain

    Brief Pain Inventory - Short Form (BPI-SF) ; 9 items ; Scores from 0 to 10 ; scores are computed into mean score ; higher scores mean higher levels of pain (negative outcome)

    Measured: Intervention group: Two times per week (before and after each session)/Control group: One time per week, For all: from enrollment to the end of intervention at 6 weeks and at a 3 weeks follow-up

Secondary outcomes (6)
  1. Anxiodepressive symptoms

    Hospital Anxiety and Depression Scale (HADS) ; 14 items: 7 items for anxiety, 7 items for depression ; Lickert scale from 0 to 3 ; a mean score is computed for each subscale (anxiety, depression) ; Minimum score for each scale: 0 ; Maximum score for each scale: 21 ; Higher scores mean worst symptomatology (negative outcome)

    Measured: Intervention group: Two times per week (before and after each session)/Control group: One time per week, For all: from enrollment to the end of intervention at 6 weeks and at a 3 weeks follow-up

  2. Quality of life

    Short-Form Health Survey 12 items (SF-12) ; includes 12 items measuring 8 dimensions (physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health) ; the physical (PCS-12) and mental (MCS-12) scales are transformed to have a mean of 50 and a standard deviation of 10 in the general U.S. population ; participants' scores represent the difference compared to the population average (measured in standard deviations) ; scores above 50 indicate a better-than-average health-related quality of life (positive outcome), while scores below 50 suggest below-average health-related quality of life (negative outcome).

    Measured: Intervention group: Two times per week (before and after each session)/Control group: One time per week, For all: from enrollment to the end of intervention at 6 weeks and at a 3 weeks follow-up

  3. Fatigue

    Multidimensional Fatigue Inventory - 10 Items (MFI-10) ; 10 items measuring 5 dimensions (general fatigue, physical fatigue, mental fatigue, reduction in activity and reduction in motivation) ; the Lickert scale ranges from 1 to 5 ; the answer on the scale represents the score of each individual item which is then added up to a sum for each dimension ; scores per dimension can vary between 4 and 20 ; higher scores indicate higher fatigue levels (negative outcome)

    Measured: From enrollment, each week during 6 weeks, Intervention group: Two times per week (before and after each session)

  4. Relaxation

    Relaxation State Questionnaire (RSQ) ; 10 items ; Lickert scales from 1 to 5 ; scores are computed into a mean score; higher scores indicate higher levels of relaxation (positive outcome)

    Measured: From enrollment, each week during 6 weeks, Intervention group: Two times per week (before and after each session)

  5. Perceived changes

    Three free items evaluating perceived change in pain, anxiodepressive symptoms, and quality of life ; Lickert scale ranging from 1 to 10 ; higher scores indicate greater perceived changes (positive outcome)

    Measured: From Session 2, each week during 5 weeks, Intervention group: Two times per week (before and after each session)

  6. Cybersickness

    Cybersickness questionnaire ; 16 items including 2 subscales (nausea and oculomotor); Lickert scale ranging from 0 to 3 ; scores for each subscale are summed to give final scores ; higher scores indicate higher levels of cybersickness (negative outcome)

    Measured: From enrollment, each week during 6 weeks, Intervention group: One time per week (after each session)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2025
  2. Study startApr 2025 (estimated)
  3. Primary completionSep 2025 (estimated)
  4. Study completionSep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Care provider
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06833905
Sponsor's protocol ID
2024-3539
Acronym
VRHArthrisis
Status last verified
Mar 2025
First submitted
13 Jan 2025
Last updated
19 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IPD that underlie results in a publication will be shared in a dedicated OSF repository.

Publications

  • Fournier V, Simard MF, Yuen SY, Guine J, Rousseaux F, Lebeau J, Jerbi K, Richebe P, Landry M, Rainville P, Ogez D. Combining virtual reality and hypnosis to alleviate chronic pain in elderly with hand arthritis: protocol for a randomised phase II clinical trial. BMJ Open. 2025 Oct 5;15(10):e103841. doi: 10.1136/bmjopen-2025-103841.

    PubMed 41047257

Questions about this trial

What is this clinical trial studying?

A study testing Virtual reality: Beach, Virtual Reality: Forest and Hypnosis: Magic Hand in people with Arthritis and Arthritis/Arthrosis, run by Ciusss de L'Est de l'Île de Montréal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Valentyn Fournier, Ph.D. (438-738-0627, valentyn.fournier.cemtl@ssss.gouv.qc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived pain (time frame: Intervention group: Two times per week (before and after each session)/Control group: One time per week, For all: from enrollment to the end of intervention at 6 weeks and at a 3 weeks follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06833905, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in